BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.01B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$623M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$175M |
| 4 |
Merck
MRK
|
+$138M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$949M |
| 2 |
Bank of America
BAC
|
+$275M |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$208M |
| 4 |
Canadian National Railway
CNI
|
+$154M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.39% |
| 2 | Financials | 8.44% |
| 3 | Consumer Discretionary | 6.01% |
| 4 | Industrials | 6% |
| 5 | Healthcare | 5.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCPC
1851
Balchem Corp
BCPC
$5.67B
| $144K | ﹤0.01% |
2,586
+1,868
| +260% | +$107K |
|
1852
AZZ Inc
AZZ
$4.54B
| $142K | ﹤0.01% |
2,743
+2,133
| +350% | +$104K |
|
1853
Protalix BioTherapeutics
PLX
$180M
| $142K | ﹤0.01% |
7,282
-1,468
| -17% | -$30.5K |
|
|
SHPG
1854
DELISTED
Shire pic
SHPG
| $142K | ﹤0.01% |
587
+87
| +17% | +$21.6K |
|
1855
Huron Consulting
HURN
$2.43B
| $142K | ﹤0.01% |
2,022
+1,460
| +260% | +$95.6K |
|
1856
iShares 7-10 Year Treasury Bond ETF
IEF
$47.2B
| $142K | ﹤0.01% |
1,349
| – | – |
|
1857
Enerpac Tool Group
EPAC
$1.88B
| $141K | ﹤0.01% |
6,127
+4,512
| +279% | +$108K |
|
|
TUMI
1858
DELISTED
TUMI HLDGS INC COM
TUMI
| $141K | ﹤0.01% |
6,880
+4,102
| +148% | +$89.6K |
|
1859
Capitol Federal Financial
CFFN
$1.08B
| $141K | ﹤0.01% |
11,703
+8,295
| +243% | +$101K |
|
|
SJI
1860
DELISTED
South Jersey Industries, Inc.
SJI
| $141K | ﹤0.01% |
5,693
+4,119
| +262% | +$108K |
|
1861
Old National Bancorp
ONB
$10.4B
| $141K | ﹤0.01% |
9,732
+6,931
| +247% | +$97.5K |
|
|
VISN
1862
Vistance Networks Inc
VISN
$2.64B
| $140K | ﹤0.01% |
4,590
+3,221
| +235% | +$97.9K |
|
1863
WD-40
WDFC
$3.09B
| $140K | ﹤0.01% |
1,606
+1,250
| +351% | +$106K |
|
1864
CoStar Group
CSGP
$13.2B
| $139K | ﹤0.01% |
6,900
-170
| -2% | -$3.47K |
|
|
TBI
1865
Trueblue
TBI
$313M
| $138K | ﹤0.01% |
4,630
+3,650
| +372% | +$103K |
|
1866
FirstCash
FCFS
$9.26B
| $138K | ﹤0.01% |
3,030
+2,346
| +343% | +$112K |
|
1867
B&G Foods
BGS
$295M
| $138K | ﹤0.01% |
4,821
+3,550
| +279% | +$107K |
|
1868
Forum Energy Technologies
FET
$967M
| $137K | ﹤0.01% |
338
+267
| +376% | +$115K |
|
1869
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.6B
| $137K | ﹤0.01% |
5,000
-2,500
| -33% | -$72.9K |
|
|
BECN
1870
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $137K | ﹤0.01% |
4,128
+2,957
| +253% | +$93.1K |
|
|
MDAS
1871
DELISTED
MEDASSETS INC COM STK (DE)
MDAS
| $136K | ﹤0.01% |
6,178
+4,732
| +327% | +$98.7K |
|
1872
MGE Energy Inc
MGEE
$3.1B
| $136K | ﹤0.01% |
3,516
+2,690
| +326% | +$109K |
|
|
TVPT
1873
DELISTED
Travelport Worldwide Limited
TVPT
| $136K | ﹤0.01% |
9,876
+9,161
| +1,281% | +$141K |
|
1874
Dolby
DLB
$5.83B
| $136K | ﹤0.01% |
3,416
+2,369
| +226% | +$93.8K |
|
1875
PTC Therapeutics
PTCT
$6B
| $136K | ﹤0.01% |
2,816
+2,232
| +382% | +$130K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2015 Portfolio in Review
As of Q2 2015, BNP Paribas Financial Markets held 3,782 positions worth $35.8B, down 0.81% from $36.1B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
BNP Paribas Financial Markets's Q2 2015 filing shows 210 new, 2,320 increased, 874 reduced and 237 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 300,000 shares worth $56.7M. The largest sale was Apple, an estimated $949M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 14% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q2 2015 buy was Vanguard S&P 500 ETF: 300,000 shares worth $56.7M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.01B increase.
- BNP Paribas Financial Markets's biggest Q2 2015 reduction was Apple, cutting an estimated $949M.
- BNP Paribas Financial Markets fully exited Allergan plc in Q2 2015, selling an estimated $55.7M.
- BNP Paribas Financial Markets's ten largest holdings make up 42% of its $35.8B portfolio in Q2 2015.
- BNP Paribas Financial Markets opened 210 new positions and closed 237 in Q2 2015.
- BNP Paribas Financial Markets's portfolio value fell 0.81% quarter-over-quarter to $35.8B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2015, filed 14 Aug 2015.